Last Modified: March 20, 2008
Conference Dates: November 4 - November 8, 2008
Conference Location: Marriott Marquis Hotel, New York City
Sponsoring Group: Mount Sinai School Of Medicine
Conference Web Page URL: www.chemotherapyfoundationsymposium.org
Topics Covered: Pediatric Oncology, Hematologic malignancies, GI Cancers, Gynecological cancers, Head and neck cancers, Thyroid cancer, Breast Cancer, Uro-oncology, Prostate, Renal, Bladder Cancers, Lung Cancer, Neuroendocrine, Gliomas, Melanoma, Solid turmors
Conference Objectives: To provide practicing oncologists with the information on new developments in cancer therapeutics
Who Should Attend: Oncologists, Hematologists, pediatric oncologists, radiotherapists, Immunologists, Oncololgy Nurses, PA's, Case Managers, Pharmacists
Conference Fees: $485 for physicians and $150 for house staff, fellows, nursing personnel, pharmacists and other cancer care providers.
Continuing Education: Yes. Mount Sinai School of Medicine designates this continuing medical education activity for a maximum of 31.0 category 1 credits toward the AMA physician's Recognition Award.
Jan 20, 2011 - The combination of chemotherapy with intensity-modulated radiation therapy is equally as effective for the treatment of anal cancer after two years as the combination of chemotherapy and conventionally delivered radiation therapy, as well as less toxic, according to a study presented at the American Society of Clinical Oncology's annual Gastrointestinal Cancers Symposium, held from Jan. 20 to 22 in San Francisco.